Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma

Hepatology. 2010 Oct;52(4):1524. doi: 10.1002/hep.23763.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular / drug therapy
  • Carcinoma, Hepatocellular / physiopathology*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Intracellular Signaling Peptides and Proteins / antagonists & inhibitors
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / physiopathology*
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism*
  • Signal Transduction / drug effects
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases

Substances

  • Immunosuppressive Agents
  • Intracellular Signaling Peptides and Proteins
  • MTOR protein, human
  • Protein Serine-Threonine Kinases
  • TOR Serine-Threonine Kinases
  • Sirolimus